Trademark: 85632415
Word
SILANES
Status
Dead
Status Code
710
Status Date
Friday, July 23, 2021
Serial Number
85632415
Registration Number
4654888
Registration Date
Tuesday, December 16, 2014
Mark Type
3000
Filing Date
Tuesday, May 22, 2012
Published for Opposition
Tuesday, May 13, 2014
Cancellation Date
Friday, July 23, 2021

Trademark Owner History
Laboratorios Silanes S.A. DE C.V. - Original Registrant

Classifications
5 Pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspensions, medicated syrups and ointments, all for treatment as a cough suppressant, and expectorant, having activity against anaerobic bacteria, trichomona vaginalis, entamoeba histolytica, and giardia lamblia, as an antifungal agent for treatment of oropharyngeal and esophageal candidiasis, candidal urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietics, antifungal agents for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infections of the skin and nails, sulphonylurea and biguanide, hipoglycaemic agent, activity against trichomonas vaginalis, entamoeba histolytica and giardia lamblia, anaerobic bacteria, histamine h1-receptor antagonist and prophylactic treatment of asthma, and treatment of allergic conditions such as rhinitis and conjunctivitis, analgesic, anti-inflamatory non steroidal, for inhibiting prostaglandin synthetase, analgesic, anti-inflammatory non steroidal, inhibitor of prostaglandin synthetase and muscle relaxant, analgesic, antipyretic, sulphonylurea hipoglycaemic agent, for inhibiting as an angiotensin-converting enzyme, treatment of congestive heart failure and asymptomatic left ventricular dysfunction, diuretic treatment of congestive heart failure, hypertension, cardiac, renal hepatogenic oedema, peripheral neuritis, neuralgias and analgesic, a broad spectrum antibiotic, effective against a wide range of gram positive and gram negative aerobic and anaerobic bacterias, histamine h2-receptor antagonist in the treatment of gastric and duodenal ulcer, zollinger-ellison syndrome, for iron deficiency and anemia for children or adults, anixolytic , anticonvulsant, sedative, muscle relaxant, histamine h2-receptor antagonist in the treatment of gastric and duodenal ulcer zollinger-ellison syndrome, multivitamin treatment and prevention of vitamin b1-b6-b12 deficiency, tricyclic antidepressant, treatment of nocturnal enuresis in children, inhibition of angiotensin-converting enzyme, treatment of hypertension and congestive heart failure, treatment and prevention of vitamin C deficiency, treatment and prevention of seborrhea and dandruff, and as an analgesic not narcotic
Color is not claimed as a feature of the mark.
The mark consists of the term "SILANES" on a wire globe, surrounded by two arching bars spanning the front of the globe.
as to "SILANES"

Trademark Events
Jul 23, 2021
Cancelled Sec. 8 (6-Yr)
Dec 16, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 16, 2014
Registered-Principal Register
Sep 9, 2014
1(B) Basis Deleted; Proceed To Registration
Aug 24, 2014
Notice Of Allowance Cancelled
Aug 29, 2014
Case Assigned To Intent To Use Paralegal
Aug 24, 2014
Teas Delete 1(B) Basis Received
Jul 8, 2014
Noa E-Mailed - Sou Required From Applicant
May 13, 2014
Official Gazette Publication Confirmation E-Mailed
May 13, 2014
Published For Opposition
Apr 23, 2014
Notification Of Notice Of Publication E-Mailed
Apr 9, 2014
Law Office Publication Review Completed
Apr 8, 2014
Approved For Pub - Principal Register
Apr 8, 2014
Data Modification Completed
Apr 7, 2014
Teas/Email Correspondence Entered
Apr 7, 2014
Correspondence Received In Law Office
Mar 30, 2014
Teas Response To Office Action Received
Nov 22, 2013
Notification Of Non-Final Action E-Mailed
Nov 22, 2013
Non-Final Action E-Mailed
Nov 22, 2013
Non-Final Action Written
Oct 31, 2013
Teas/Email Correspondence Entered
Oct 30, 2013
Correspondence Received In Law Office
Oct 30, 2013
Teas Response To Suspension Inquiry Received
Oct 30, 2013
Teas Change Of Correspondence Received
Jul 17, 2013
Notification Of Letter Of Suspension E-Mailed
Jul 17, 2013
Letter Of Suspension E-Mailed
Jul 17, 2013
Suspension Letter Written
Jun 7, 2013
Teas/Email Correspondence Entered
Jun 7, 2013
Correspondence Received In Law Office
May 30, 2013
Assigned To Lie
May 28, 2013
Notice Of Revival - E-Mailed
May 27, 2013
Teas Response To Office Action Received
May 27, 2013
Petition To Revive-Granted
May 27, 2013
Teas Petition To Revive Received
Apr 17, 2013
Abandonment Notice Mailed - Failure To Respond
Apr 17, 2013
Abandonment - Failure To Respond Or Late Response
Sep 19, 2012
Notification Of Non-Final Action E-Mailed
Sep 19, 2012
Non-Final Action E-Mailed
Sep 19, 2012
Non-Final Action Written
Sep 11, 2012
Assigned To Examiner
May 31, 2012
Notice Of Design Search Code Mailed
May 30, 2012
New Application Office Supplied Data Entered In Tram
May 25, 2012
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24